CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Clinical trials for CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE trials appear
Sign up with your email to follow new studies for CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Two-Step transplant aims to cut deaths in blood cancer patients
Disease control Recruiting nowThis study tests a two-step approach to bone marrow transplant using lower doses of radiation and chemotherapy before the transplant. The goal is to see if this gentler method reduces the number of patients who die from treatment side effects. The study includes adults with vario…
Matched conditions: CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
New stem cell combo shows promise against tough blood cancers
Disease control Recruiting nowThis study tests a stem cell transplant from half-matched (haploidentical) donors for people with various blood cancers. Before the transplant, patients receive chemotherapy and low-dose radiation to prepare the body. The goal is to see if this approach helps control the cancer a…
Matched conditions: CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New cord blood transplant method offers hope for tough blood cancers
Disease control Recruiting nowThis study tests a special cord blood transplant for people with high-risk blood cancers like leukemia and lymphoma. Participants receive chemotherapy and radiation before the transplant to kill cancer cells, then donor stem cells to rebuild healthy blood. After transplant, drugs…
Matched conditions: CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Engineered immune cells take aim at returning leukemia after transplant
Disease control Recruiting nowThis early-stage study tests a new treatment for children and adults whose acute leukemia has come back or not responded after a donor stem cell transplant. The treatment uses specially engineered immune cells (T cells) from the original donor that are trained to recognize and at…
Matched conditions: CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Phase: PHASE1 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
Donor vaccine aims to shield transplant patients from dangerous virus
Prevention Recruiting nowThis study tests a vaccine (CMV-MVA Triplex) given to stem cell donors to help prevent CMV infection in patients receiving a stem cell transplant. The vaccine boosts the donor's immunity against CMV, which is then passed to the patient through the transplant. About 216 donor-reci…
Matched conditions: CHRONIC MYELOID LEUKEMIA, BCR-ABL1 POSITIVE
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Prevention
Last updated Apr 30, 2026 15:52 UTC